Mark McDade, CEO at PDL BIOPHARMA, INC. (PDLI), sold 10,000 shares at $20.81 ($209K) on 2007-01-12, disclosed to the SEC on 2007-01-17.
Scheduled sale ($209k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.80 | 800 | $17K | 8.0% |
| 2 | $20.81 | 200 | $4K | 2.0% |
| 3 | $20.82 | 1,000 | $21K | 10.0% |
| 4 | $20.87 | 1,000 | $21K | 10.0% |
| 5 | $20.89 | 1,100 | $23K | 11.0% |
| 6 | $20.90 | 1,000 |
| $21K |
| 10.0% |
| 7 | $20.90 | 900 | $19K | 9.0% |
| 8 | $20.92 | 1,000 | $21K | 10.0% |
| 9 | $20.93 | 1,000 | $21K | 10.0% |
| 10 | $20.94 | 2,000 | $42K | 20.0% |
| Total | $20.89 avg | 10,000 | $209K | 100% |
| Filing → |
| AIMT | BUY | 2015-08-11 | $267K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-07-17 | $9K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-05-08 | $9K | — | Filing → |